"FDA's action adds yet another anti-HIV product to those available for purchase under the President's Plan and demonstrates our continuing commitment to ensuring that safe, effective, and quality manufactured medications are available for purchase under the President's Plan," said Murray M. Lumpkin, M.D., Deputy Commissioner for International and Special Programs.
Abacavir, like it's branded counterpart, GlaxoSmithKline's Ziagen, non-nucleoside reverse transcriptase inhibitor (NRTIs), a class of drugs that inhibits HIV reproduction.
Read more from RxPG News.
.jpg)
Comment Preview